Scarica l'app Stockscreener
94.95
4.75%
-4.73
Pre-mercato:
95.42
0.47
+0.49%
Mesa Laboratories Inc Borsa (MLAB) Ultime notizie
Mesa Laboratories appoints Lyndsey Crennen as chief accounting officer - Investing.com
Mesa Laboratories Promotes Lyndsey Crennen to Chief Accounting Officer - TipRanks
Mesa Laboratories appoints Lyndsey Crennen as chief accounting officer By Investing.com - Investing.com UK
Lyndsey Crennen named Chief Accounting Officer at Mesa - TradingView
Mesa Laboratories, Inc. Announces Appointment of Lyndsey Crennen as Chief Accounting Officer - marketscreener.com
Mesa Laboratories (MLAB) appoints Lyndsey Crennen Chief Accounting Officer - Stock Titan
Mesa Laboratories (MLAB) Weakens Amid Sector Headwinds, Testing Key Support LevelsShort Setup Alerts - newsline.com
MLAB Q1 2026 Earnings: EPS Misses Estimates by Significant Margin, Stock DeclinesRevenue Breakdown Analysis - newsline.com
Mesa Laboratories (MLAB) Sees Modest Gains Amid Consolidation Above Key SupportWedge Breakout - newsline.com
MLAB Q1 2026 Earnings: Significant EPS Miss Amid Negative SurpriseFinancial Data - newsline.com
MLAB Q1 2026 Earnings: Significant EPS Miss Despite Surprise Stock GainProfitability Analysis - newsline.com
Mesa Laboratories Stock Slides 4.8%: Key Support Level in FocusHull Moving Average - newsline.com
3 Stocks Estimated To Be Trading 16.4% To 42% Below Intrinsic Value - simplywall.st
MLAB Q1 2026 Earnings: Significant EPS Miss Amidst Operational ChallengesEarnings Whisper Number - newsline.com
Mesa Laboratories Inc. (MLAB) Declines 4.19% as Shares Test Key Support LevelsSector ETF Flow - newsline.com
Mesa Laboratories : Annual Report for Fiscal Year Ending 03-31, 2026 (Form 10-K) - marketscreener.com
Mesa Laboratories, Inc. 2026 Annual Report: Business Overview, Strategy, Segments, and Key Risk Factors - Minichart
Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005. - marketscreener.com
Mesa Laboratories (NASDAQ: MLAB) outlines global segments, GKE deal and key risks - Stock Titan
MLAB Q1 2026 Earnings: EPS Soars Past Estimates by 695%, Revenue Data UnavailableProfit Guidance Range - The Legal Advocate
Mesa Laboratories (MLAB) Slips 1.05% as Stock Nears Support ZoneStock Buy Zone - The Legal Advocate
Jefferies raises Mesa Laboratories stock price target on CEO outlook By Investing.com - Investing.com Nigeria
Jefferies raises Mesa Laboratories stock price target on CEO outlook - Investing.com
Mesa Labs 4Q Rev $63.7M >MLAB - Moomoo
Mesa Labs 4Q Loss $4.14M >MLAB - Moomoo
Mesa Labs earnings beat by $1.76, revenue fell short of estimates - Investing.com Canada
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today - The Motley Fool
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today - The Motley Fool
Mesa Laboratories' Stock Slips as 4Q Growth Misses Targets - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Mesa Labs 4Q Loss/Shr 75c >MLAB - Moomoo
Is Mesa Laboratories (MLAB) Modestly Undervalued Despite Q4 FY26 - GuruFocus
Mesa Laboratories Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Press Release: Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results - Moomoo
MESA LABORATORIES ($MLAB) Releases Q4 2026 Earnings - Quiver Quantitative
Mesa Labs: Fiscal Q4 Earnings Snapshot - marketscreener.com
Mesa Laboratories reports FY26 revenue $249.1M, operating income $18.5M, AOI ex-unusual $63.5M - TradingView
Mesa Laboratories (NASDAQ: MLAB) grows FY26 revenue 3.4% as margins expand - Stock Titan
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results - GlobeNewswire
Mesa Laboratories Inc. (MLAB) Q1 2026 Earnings: Strong EPS Surprise of 130% Amid Quiet Revenue DisclosureEPS Miss Report - The Legal Advocate
MLAB Q1 2026 Earnings: Significant EPS Beat Driven by Strong Operational PerformanceRevenue Warning Signal - The Legal Advocate
MLAB Q1 2026 Earnings: Earnings Per Share Surges Past Estimates by Over 130%High Growth Earnings - newsline.com
Mesa Laboratories Inc. (MLAB) Q1 2026 Earnings: Stellar EPS Surprise of 130% Drives Optimism Amidst Quiet Revenue PeriodRevenue Growth Report - Newser
Mesa Labs Stock Pops Before the Date Investors Can’t Ignore - Bez Kabli
MLAB Q4'25 Earnings: revenue estimate is 65.21M USD - TradingView
Mesa Laboratories (MLAB) CEO awarded 35,236 restricted stock units in Form 4/A - Stock Titan
Mesa Laboratories stock (US59064R1095): Precision tools for life sciences - AD HOC NEWS
MLAB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MLAB Mesa Laboratories posts 130% earnings beat, but MLAB shares fall 1.39% despite strong 11.5% revenue growth.Shared Momentum Picks - Newser
Mesa Laboratories Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026 - Weekly Voice
Mesa Laboratories, Inc. Scheduled to Release Q4 and Fiscal Year 2026 Financial Results on May 27, 2026 - Quiver Quantitative
Mesa Labs sets May 27 release for full-year and Q4 results - Stock Titan
1.57%
1.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):